Strong CapitalizationA high equity ratio (63.78%) and improved debt-to-equity (0.41) indicate durable capitalization and lower refinancing risk. Combined with a 13.75% ROE, this supports sustained investment in R&D and operations, and provides a buffer through biotech cycles for 2-6 months plus.

Healthy Profitability MarginsRobust gross and operating margins show structural pricing power and cost control across the business model. Sustained EBIT/EBITDA margins near 19%/27% provide durable internal funding for growth initiatives and reduce dependency on external financing over the medium term.

Improving Cash GenerationOperating cash flow converting at 1.15x of net income signals quality earnings and effective cash collection. A 7.52% free cash flow growth trend indicates improving ability to self-fund capex and R&D, enhancing financial flexibility over the coming months.

Bears Say

Low Free Cash Flow ConversionA free cash flow to net income ratio of 0.04 shows most reported profits are not translating into distributable cash. This constrains capacity for dividends, buybacks, or unexpected capex, leaving the company more exposed to shocks despite improving trends.

EBIT VolatilityNoticeable EBIT volatility implies earnings drivers are uneven, which complicates budgeting and strategic planning in a capital-intensive biotech context. Persistent swings can erode investor confidence and hamper consistent reinvestment decisions over a multi-quarter horizon.

EPS ContractionA reported EPS decline of ~20% signals pressure on per-share earnings that may reflect dilution, one-offs, or operating headwinds. Even with margin and revenue strengths, falling EPS is a structural concern for shareholder returns and long-term profit consistency.

177A FAQ

What was Kohjin Bio Co.,Ltd.’s price range in the past 12 months?

Kohjin Bio Co.,Ltd. lowest stock price was ¥1161.00 and its highest was ¥2020.00 in the past 12 months.

What is Kohjin Bio Co.,Ltd.’s market cap?

Kohjin Bio Co.,Ltd.’s market cap is ¥6.17B.

When is Kohjin Bio Co.,Ltd.’s upcoming earnings report date?

Kohjin Bio Co.,Ltd.’s upcoming earnings report date is May 20, 2026 which is in 92 days.

How were Kohjin Bio Co.,Ltd.’s earnings last quarter?

Kohjin Bio Co.,Ltd. released its earnings results on Feb 13, 2026. The company reported ¥15.18 earnings per share for the quarter, beating the consensus estimate of N/A by ¥15.18.

Is Kohjin Bio Co.,Ltd. overvalued?

According to Wall Street analysts Kohjin Bio Co.,Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Kohjin Bio Co.,Ltd. pay dividends?

Kohjin Bio Co.,Ltd. pays a Notavailable dividend of ¥24 which represents an annual dividend yield of 1.62%. See more information on Kohjin Bio Co.,Ltd. dividends here

What is Kohjin Bio Co.,Ltd.’s EPS estimate?

Kohjin Bio Co.,Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Kohjin Bio Co.,Ltd. have?

Kohjin Bio Co.,Ltd. has 5,111,600 shares outstanding.

What happened to Kohjin Bio Co.,Ltd.’s price movement after its last earnings report?

Kohjin Bio Co.,Ltd. reported an EPS of ¥15.18 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.548%.

Which hedge fund is a major shareholder of Kohjin Bio Co.,Ltd.?

Currently, no hedge funds are holding shares in JP:177A

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Kohjin Bio Co.,Ltd.

Kohjin Bio Co., Ltd. is a biotechnology company specializing in the development and production of bioactive compounds and fermentation products. The company operates primarily in the health and wellness sectors, focusing on nutritional supplements, functional foods, and pharmaceutical intermediates. Kohjin Bio is known for its innovative approaches to biotechnology, leveraging fermentation technology to create high-quality, bioavailable ingredients that cater to a growing market for health-conscious consumers.